Your browser doesn't support javascript.
loading
A pilot study of multi-antigen stimulated cell therapy-I plus camrelizumab and apatinib in patients with advanced bone and soft-tissue sarcomas.
Zhou, Yan; Li, Mei; Zhang, Bing; Yang, Cheng; Wang, Yaling; Zheng, Shuier; Tang, Lina; Zhou, Chenliang; Qian, Guowei; Huang, Yujing; Yu, Wenxi; Li, Hongtao; Wang, Yonggang; He, Aina; Shen, Zan; Zhang, Jianjun; Li, Xiaoshuang; Yang, Qingcheng; Hu, Haiyan; Yao, Yang.
Affiliation
  • Zhou Y; Department of Oncology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China.
  • Li M; Department of Radiology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Zhang B; Department of Orthopedic Oncology, the Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Jiangxi, China.
  • Yang C; Department of Orthopedic Oncology, Changzheng Hospital of Naval Military Medical University, Shanghai, China.
  • Wang Y; Department of Oncology, Shanghai Eighth People's Hospital, Shanghai, China.
  • Zheng S; Department of Oncology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China.
  • Tang L; Department of Oncology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China.
  • Zhou C; Department of Oncology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China.
  • Qian G; Department of Oncology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China.
  • Huang Y; Department of Oncology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China.
  • Yu W; Department of Oncology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China.
  • Li H; Department of Oncology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China.
  • Wang Y; Department of Oncology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China.
  • He A; Department of Oncology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China.
  • Shen Z; Department of Oncology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China.
  • Zhang J; Department of Oncology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. robustzhang168@aliyun.com.
  • Li X; HRYZ Biotech Co, Shenzhen, China.
  • Yang Q; Department of Orthopedic, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China. tjyqc@163.com.
  • Hu H; Department of Oncology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China. xuri1104@163.com.
  • Yao Y; Shanghai Clinical Research Ward (SCRW), Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China. xuri1104@163.com.
BMC Med ; 21(1): 470, 2023 11 29.
Article in En | MEDLINE | ID: mdl-38031088

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sarcoma Limits: Humans Language: En Journal: BMC Med Journal subject: MEDICINA Year: 2023 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sarcoma Limits: Humans Language: En Journal: BMC Med Journal subject: MEDICINA Year: 2023 Document type: Article Affiliation country: Country of publication: